{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:32:03Z","timestamp":1777318323086,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,8]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Pyoderma gangrenosum (PG) is a rare noninfectious neutrophilic skin disease. The diagnosis of PG is mainly based on clinical manifestations. Therefore, the clinical features of PG are important for confirming the diagnosis of this disease. Herein, the clinical data of 2 young males with PG complicated with hematological malignancies were reported, and the literature were reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>The first case was a 22-year-old male who was admitted due to a systemic rash, headache, and fever. Physical examination showed black scabs on the skins of the extremities, trunk, scalp, and face. Biopsy of the skin lesion showed epidermal edema, spongy formation, neutrophil infiltration, acute and chronic inflammatory cell infiltration in the dermis, showing purulent inflammation with epidermal erosion. The bone marrow biopsy showed obviously active proliferation of nucleated cells, granulocytes at various stages, abnormal morphological neutrophils, and occasionally observed young red blood cells. The diagnosis of PG and chronic myelomonocytic leukemia (CMML-0) was made. The second case was a 28-year-old male who presented a swollen, painful right calf following injury and then developed ulcers on skin and soft tissues. Bone marrow biopsy showed obviously active nucleated cell proliferation, suggesting a myeloid tumor. He was also diagnosed with PG and hematological malignancies. They both received hormone and antiinfection therapy. After treatment, their body temperature, infection, and skin lesions were improved. However, both of them were readmitted and had a poor prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>PG may be associated with hematological malignancies. For patients with typical skin lesions and obvious abnormal blood routines, it is necessary to investigate the possibility of PG with hematological malignancies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037159","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:01:58Z","timestamp":1709928118000},"page":"e37159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Pyoderma gangrenosum complicated with hematological malignancies: Two case reports"],"prefix":"10.1097","volume":"103","author":[{"given":"Fen","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanan","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-4919","authenticated-orcid":false,"given":"Xuezhong","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First People\u2019s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China"},{"name":"Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032 Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments.","volume":"23","author":"Maronese","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-020-0213-x","article-title":"Pyoderma gangrenosum.","volume":"6","author":"Maverakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000509745","article-title":"Postsurgical pyoderma gangrenosum in a breast cancer patient: a case report and literature review.","volume":"14","author":"Vernaci","year":"2021","journal-title":"Case Rep Oncol"},{"key":"R4-20250503","first-page":"374","article-title":"Neutrophilic dermatoses\u2014Pathomechanistic concepts and therapeutic developments.","volume":"21","author":"Bonnekoh","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/09546634.2018.1506083","article-title":"Biologic and small-molecule medications in the management of pyoderma gangrenosum.","volume":"30","author":"McKenzie","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria?","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management.","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.14309\/ajg.0000000000001972","article-title":"A rare complication: postoperative pyoderma gangrenosum in segmental colitis associated with diverticulosis.","volume":"117","author":"Dunleavy","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts.","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/jdv.16034","article-title":"Peristomal ulcers misdiagnosed as pyoderma gangrenosum: a common error.","volume":"34","author":"Barton","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jamadermatol.2021.5001","article-title":"Pyoderma Gangrenosum.","volume":"158","author":"Hou","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1440-1827.2009.02418.x","article-title":"Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis.","volume":"59","author":"Nomura","year":"2009","journal-title":"Pathol Int"},{"key":"R14-20250503","first-page":"127","article-title":"Clinicopathological manifestations of 52 cases of histocytic necrotizing lymphadenitis.","author":"Xu","year":"2006","journal-title":"Chin J Intern Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2141.1998.00900.x","article-title":"Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript.","volume":"102","author":"Hamaguchi","year":"1998","journal-title":"Br J Haematol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.leu.2404233","article-title":"A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare \u201cpoor prognosis\u201d myeloid malignancies.","volume":"20","author":"Slovak","year":"2006","journal-title":"Leukemia"},{"key":"R17-20250503","first-page":"1293","article-title":"Characteristics of 11 patients with acute myeloid leukemia accompanied with karyotype aberration t(6;9).","volume":"20","author":"Lai","year":"2012","journal-title":"Chin J Experiment Hematol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"e29655","DOI":"10.1002\/pbc.29655","article-title":"Abscess-like skin and lung lesions in a patient with acute lymphoblastic leukemia: pyoderma gangrenosum.","volume":"69","author":"Akyol","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/ijd.ijd_1133_20","article-title":"Pure bullous pyoderma gangrenosum, a challenging clinico-pathological diagnosis: critical literature review with emphasis on diagnostic criteria.","volume":"67","author":"Garcia-Abellas","year":"2022","journal-title":"Indian J Dermatol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1346-8138.2003.tb00334.x","article-title":"Bullous pyoderma gangrenosum complicated by disseminated intravascular coagulation with subsequent myelodysplastic syndrome (chronic myelomonocytic leukemia).","volume":"30","author":"Rogalski","year":"2003","journal-title":"J Dermatol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"e12697","DOI":"10.1111\/dth.12697","article-title":"Efficacy of topical calcineurin inhibitors in pyoderma gangrenosum.","volume":"31","author":"Abdul-Fattah","year":"2018","journal-title":"Dermatol Ther"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archdermatol.2010.393","article-title":"Is topical monotherapy effective for localized pyoderma gangrenosum?","volume":"147","author":"Le Cleach","year":"2011","journal-title":"Arch Dermatol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-4632.2011.05451.x","article-title":"Pyoderma gangrenosum\u2014a review of 24 cases observed over 10 years.","volume":"52","author":"Pereira","year":"2013","journal-title":"Int J Dermatol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2230.2010.03941.x","article-title":"Pyoderma gangrenosum: an Indian perspective.","volume":"36","author":"Bhat","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"5 Pt 2","key":"R27-20250503","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0190-9622(92)70252-B","article-title":"Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia.","volume":"27","author":"Ho","year":"1992","journal-title":"J Am Acad Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:21:01Z","timestamp":1746318061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037159","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]}}}